Medline (MDLN) Receivables (2024 - 2026)

Medline (MDLN) has 3 years of Receivables data on file, last reported at $3.7 billion in Q1 2026.

• On a quarterly basis, Receivables changed N/A year-over-year to $3.7 billion in Q1 2026; TTM through Mar 2026 was $3.7 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $3.5 billion, up 9.75% from the prior year.
• Receivables for Q1 2026 stood at $3.7 billion, up from $3.5 billion in the prior quarter.
• Over the last five years, Receivables for MDLN reached as high as $3.7 billion in Q1 2026 and fell as low as $3.2 billion in Q4 2024.
• Historically, Receivables has averaged $3.5 billion across 3 years, with a median of $3.5 billion in 2025.
• On a YoY basis, Receivables climbed as much as 9.75% in 2025 and fell as far as 9.75% in 2025.
• Year by year, Receivables stood at $3.2 billion in 2024, then advanced by 9.75% to $3.5 billion in 2025, then climbed by 3.99% to $3.7 billion in 2026.
• Per Business Quant data, the three most recent Receivables figures were $3.7 billion in Q1 2026, $3.5 billion in Q4 2025, and $3.2 billion in Q4 2024.